South Korea
· Delayed Price · Currency is KRW Daewon Pharmaceutical Statistics
Total Valuation
KRX:003220 has a market cap or net worth of KRW 268.78 billion. The enterprise value is 421.66 billion.
| Market Cap | 268.78B |
| Enterprise Value | 421.66B |
Important Dates
The last earnings date was Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
KRX:003220 has 21.43 million shares outstanding. The number of shares has decreased by -1.15% in one year.
| Current Share Class | 21.43M |
| Shares Outstanding | 21.43M |
| Shares Change (YoY) | -1.15% |
| Shares Change (QoQ) | +0.23% |
| Owned by Insiders (%) | 38.80% |
| Owned by Institutions (%) | 11.73% |
| Float | 12.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 76.70 |
| PS Ratio | 0.46 |
| PB Ratio | 1.02 |
| P/TBV Ratio | 1.35 |
| P/FCF Ratio | 15.49 |
| P/OCF Ratio | 6.27 |
| PEG Ratio | 1.96 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.09, with an EV/FCF ratio of 24.30.
| EV / Earnings | -26.29 |
| EV / Sales | 0.71 |
| EV / EBITDA | 18.09 |
| EV / EBIT | n/a |
| EV / FCF | 24.30 |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.81.
| Current Ratio | 1.12 |
| Quick Ratio | 0.64 |
| Debt / Equity | 0.81 |
| Debt / EBITDA | 9.67 |
| Debt / FCF | 12.30 |
| Interest Coverage | -0.05 |
Financial Efficiency
Return on equity (ROE) is -6.76% and return on invested capital (ROIC) is -0.05%.
| Return on Equity (ROE) | -6.76% |
| Return on Assets (ROA) | -0.04% |
| Return on Invested Capital (ROIC) | -0.05% |
| Return on Capital Employed (ROCE) | -0.09% |
| Revenue Per Employee | 460.40M |
| Profits Per Employee | -12.50M |
| Employee Count | 1,283 |
| Asset Turnover | 0.98 |
| Inventory Turnover | 2.97 |
Taxes
In the past 12 months, KRX:003220 has paid 8.73 billion in taxes.
| Income Tax | 8.73B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.43% in the last 52 weeks. The beta is 0.21, so KRX:003220's price volatility has been lower than the market average.
| Beta (5Y) | 0.21 |
| 52-Week Price Change | -12.43% |
| 50-Day Moving Average | 12,969.80 |
| 200-Day Moving Average | 13,388.45 |
| Relative Strength Index (RSI) | 42.87 |
| Average Volume (20 Days) | 43,074 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:003220 had revenue of KRW 590.70 billion and -16.04 billion in losses. Loss per share was -748.28.
| Revenue | 590.70B |
| Gross Profit | 265.71B |
| Operating Income | -351.12M |
| Pretax Income | -9.97B |
| Net Income | -16.04B |
| EBITDA | 22.07B |
| EBIT | -351.12M |
| Loss Per Share | -748.28 |
Balance Sheet
The company has 68.22 billion in cash and 213.42 billion in debt, giving a net cash position of -145.20 billion or -6,774.53 per share.
| Cash & Cash Equivalents | 68.22B |
| Total Debt | 213.42B |
| Net Cash | -145.20B |
| Net Cash Per Share | -6,774.53 |
| Equity (Book Value) | 263.87B |
| Book Value Per Share | 11,945.50 |
| Working Capital | 26.88B |
Cash Flow
In the last 12 months, operating cash flow was 42.85 billion and capital expenditures -25.50 billion, giving a free cash flow of 17.35 billion.
| Operating Cash Flow | 42.85B |
| Capital Expenditures | -25.50B |
| Free Cash Flow | 17.35B |
| FCF Per Share | 809.55 |
Margins
Gross margin is 44.98%, with operating and profit margins of -0.06% and -2.71%.
| Gross Margin | 44.98% |
| Operating Margin | -0.06% |
| Pretax Margin | -1.69% |
| Profit Margin | -2.71% |
| EBITDA Margin | 3.74% |
| EBIT Margin | -0.06% |
| FCF Margin | 2.94% |
Dividends & Yields
This stock pays an annual dividend of 300.00, which amounts to a dividend yield of 2.40%.
| Dividend Per Share | 300.00 |
| Dividend Yield | 2.40% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.15% |
| Shareholder Yield | 3.55% |
| Earnings Yield | -5.97% |
| FCF Yield | 6.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 7, 2022. It was a forward split with a ratio of 1.03.
| Last Split Date | Mar 7, 2022 |
| Split Type | Forward |
| Split Ratio | 1.03 |
Scores
KRX:003220 has an Altman Z-Score of 2.1 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.1 |
| Piotroski F-Score | 2 |